- Home
- GWH vs ECOR Comparison
GWH vs ECOR Comparison
Compare GWH & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWH
- ECOR
- Stock Information
- Founded
- GWH 2011
- ECOR 2005
- Country
- GWH United States
- ECOR United States
- Employees
- GWH N/A
- ECOR N/A
- Industry
- GWH Industrial Machinery/Components
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GWH Miscellaneous
- ECOR Health Care
- Exchange
- GWH Nasdaq
- ECOR Nasdaq
- Market Cap
- GWH 56.8M
- ECOR 65.0M
- IPO Year
- GWH N/A
- ECOR 2018
- Fundamental
- Price
- GWH $5.07
- ECOR $16.26
- Analyst Decision
- GWH Buy
- ECOR Strong Buy
- Analyst Count
- GWH 6
- ECOR 1
- Target Price
- GWH $2.54
- ECOR $25.00
- AVG Volume (30 Days)
- GWH 82.3K
- ECOR 143.9K
- Earning Date
- GWH 11-13-2024
- ECOR 11-13-2024
- Dividend Yield
- GWH N/A
- ECOR N/A
- EPS Growth
- GWH N/A
- ECOR N/A
- EPS
- GWH N/A
- ECOR N/A
- Revenue
- GWH $6,241,000.00
- ECOR $23,327,000.00
- Revenue This Year
- GWH $32.11
- ECOR $61.40
- Revenue Next Year
- GWH $341.09
- ECOR $38.43
- P/E Ratio
- GWH N/A
- ECOR N/A
- Revenue Growth
- GWH 31.11
- ECOR 74.10
- 52 Week Low
- GWH $4.35
- ECOR $5.25
- 52 Week High
- GWH $18.00
- ECOR $17.89
- Technical
- Relative Strength Index (RSI)
- GWH 41.97
- ECOR 63.40
- Support Level
- GWH $4.35
- ECOR $14.11
- Resistance Level
- GWH $5.30
- ECOR $17.84
- Average True Range (ATR)
- GWH 0.46
- ECOR 1.80
- MACD
- GWH 0.01
- ECOR 0.32
- Stochastic Oscillator
- GWH 42.11
- ECOR 76.31
About GWH ESS Tech Inc.
ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.